• Skip to primary navigation
  • Skip to main content
  • Skip to footer
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

Hide Search
Shopping Cart
Show SearchSearch
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
    • Our Impact
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
    • Interactive Tool
    • Other Educational Tools
    • LactRx App
  • Studies
    • Ongoing Studies
    • What’s Involved?
    • Join Now
    • Refer a Patient
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
  • Donate
  • Contact
  • Show SearchSearch

Buproprion (Wellbutrin®)

July 1, 2023

Selected References:

  • Alwan S, et al. 2010. Maternal use of bupropion and risk of congenital heart defects. Am J Obstet Gynecol 203(1):52.e1-6.
  • Anderson KN, et al 2020. Maternal use of specific antidepressants during early pregnancy and the risk of selected birth defects. JAMA Psychiatry; doi:10.1001/jamapsychiatry.2020.2453.
  • Baab S, et al. 2002. Serum bupropion levels in 2 breastfeeding mother-infant pairs. J Clin Psych 63:910-911.
  • Chaudron LH, et al 2004. Bupropion and breastfeeding: a case of possible infant seizure. J Clin Psych; 65:881-882.
  • Chun Fai-Chan B, et al. 2005. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 192(3):932-936.
  • Cole A, et al. 2007. Bupriopion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 10.1002/pds.1296.
  • Einarson T and Einarson A. 2005. Newer Antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepi Drug Saf 14:823-827.
  • Einarson A, et al. 2009. Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry;54(4):242-246.
  • Figueroa R. 2010. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. J Dev Behav Pediatr 31(8):641.
  • Haas J, et al. 2004. Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use. Tob Control 13:52-56.
  • Halbreich U, et al. 1991. Menstrual irregularities associated with bupropion treatment. J Clin Psych 52:15-16.
  • Huybrechts KF, et al. 2014. Antidepressant use in pregnancy and risk of cardiac defects. NEJM; 370:2397-2407.
  • Källén B. 2004. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 158(4):312-3016.
  • Kalra S, et al. 2005. Motherisk Update: Taking depressants during late pregnancy. Can Fam Physician 51:1077-1078.
  • Louik C, et al. 2014. First-trimester exposure to bupropion and risk of cardiac malformations. Pharmacoepidemiol Drug Saf; 23(10):1066-75.
  • Marks C, et al. 2021. Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study. Pharmacotherapy. 41(11):907-914.
  • Nanovskaya TN, et al. 2017. Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial. Am J Obstet Gynecol. 216(4):420.e1-.e9.
  • Neuman G, et al. 2014. Bupropion and Escitalopram During Lactation. Ann Pharmaco.48(7):928-31.
  • Nonacs R, et al. 2005. Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol 8(3):445-9.
  • Tharp MA, et al. 2022. Does lack of exposure to individual antidepressants at different points during pregnancy associate with reduced risk of adverse newborn outcomes? BMC Pregnancy Childbirth. 9;22(1):926.
  • The Bupropion Pregnancy Registry. Final report. 1 September 1997 through 31 March 2008. Issued August, 2008. Kendle International, Inc., Wilmington, North Carolina.

Footer

               

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Constipation
  • Coronavirus (COVID-19)
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Lupus
  • Multiple Sclerosis
  • Non-Radiographic Axial Spondyloarthritis
  • Psoriasis
  • Psoriatic Arthritis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists

Copyright © 2025 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.